Structure |
Chemical Name |
CAS |
MF |
![3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine](/CAS/GIF/1262133-64-1.gif) |
3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine |
1262133-64-1 |
C20H30FN3O9 |
![5-Chlorodescyano CitalopraM Oxalate](/CAS/GIF/64169-46-6.gif) |
5-Chlorodescyano CitalopraM Oxalate |
64169-46-6 |
C21H23ClFNO5 |
![Acyclovir N-Methyl-L-valinate Hydrochloride](/CAS/GIF/1346617-39-7.gif) |
Acyclovir N-Methyl-L-valinate Hydrochloride |
1346617-39-7 |
C14H23ClN6O4 |
![rac N,N-DidesMethyl-N-(4-hydroxyphenethyl)-O-desMethyl Venlafaxine](/CAS/20140608/GIF/CB02544106.gif) |
rac N,N-DidesMethyl-N-(4-hydroxyphenethyl)-O-desMethyl Venlafaxine |
1346601-21-5 |
C22H29NO3 |
![rac-11-Deoxy-8(12)-dehydro Misoprostol](/CAS/GIF/1331639-92-9.gif) |
rac-11-Deoxy-8(12)-dehydro Misoprostol |
1331639-92-9 |
C22H36O4 |
![5-Nitro-1H-iMidazole-1-ethanol](/CAS/GIF/5006-68-8.gif) |
5-Nitro-1H-iMidazole-1-ethanol |
5006-68-8 |
C5H7N3O3 |
![Iohexol related Compound I](/) |
Iohexol related Compound I |
|
|
![2,2'-Methylene Bis[Ranitidine]](/CAS/GIF/207592-21-0.gif) |
2,2'-Methylene Bis[Ranitidine] |
207592-21-0 |
C27H44N8O6S2 |
![ChloroMethyl Propyl Carbonate](/CAS/GIF/35273-90-6.gif) |
ChloroMethyl Propyl Carbonate |
35273-90-6 |
C5H9ClO3 |
![2-AMino-5-(trifluoroMethoxy)phenyl Thiocyanate](/CAS/20140608/GIF/CB02558642.gif) |
2-AMino-5-(trifluoroMethoxy)phenyl Thiocyanate |
1391054-04-8 |
C8H5F3N2OS |
![Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol)](/CAS/GIF/16985-05-0.gif) |
Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
16985-05-0 |
C18H15NO2 |
![Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)](/CAS/20211123/GIF/4504-96-5.gif) |
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
4504-96-5 |
C18H20ClNO |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
![Edoxaban Impurity 12 (1R,2R,4S)](/CAS/20150408/GIF/500572-10-1.gif) |
Edoxaban Impurity 12 (1R,2R,4S) |
500572-10-1 |
C24H30ClN7O4S |
![paroxetine Mesylate](/CAS/GIF/217797-14-3.gif) |
paroxetine Mesylate |
217797-14-3 |
C20H24FNO6S |
![2-(2-Ethoxyphenoxy)ethyl Methanesulfonate](/CAS/GIF/169506-15-4.gif) |
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate |
169506-15-4 |
C11H16O5S |
![1-(5-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone](/CAS/GIF/861841-94-3.gif) |
1-(5-(benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone |
861841-94-3 |
C15H13NO5 |
![acetylated penicilloic acids of piperacillin](/) |
acetylated penicilloic acids of piperacillin |
|
|
![penicilloic acids of piperacillin](/) |
penicilloic acids of piperacillin |
|
|
![RocuroniuMbroMide iMpurity B](/) |
RocuroniuMbroMide iMpurity B |
|
|
![TetrazepaM IMp. C (EP): 7-Chloro-5-cyclohexyl-1-Methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one](/) |
TetrazepaM IMp. C (EP): 7-Chloro-5-cyclohexyl-1-Methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
|
![Thiazolylacetyl glycine oxiMe](/CAS/GIF/178949-03-6.gif) |
Thiazolylacetyl glycine oxiMe |
178949-03-6 |
C7H8N4O4S |
![3-O-Decladinosyl-6-O-Methylerythronolide A](/CAS/20211123/GIF/118058-74-5.gif) |
3-O-Decladinosyl-6-O-Methylerythronolide A |
118058-74-5 |
C30H55NO10 |
![Desmethyl Ranolazine](/CAS/GIF/755711-09-2.gif) |
Desmethyl Ranolazine |
755711-09-2 |
C23H31N3O3 |
![P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester](/CAS/GIF/1255525-18-8.gif) |
P-[[(1S)-2-(6-AMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-phosphonic Acid Monoethyl Ester |
1255525-18-8 |
C11H18N5O4P |
![4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one](/CAS/GIF/763111-47-3.gif) |
4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one |
763111-47-3 |
C20H19FN4O2 |
![DESVENLAFAXINE SUCCINATE](/CAS/20210111/GIF/448904-47-0.gif) |
DESVENLAFAXINE SUCCINATE |
448904-47-0 |
C20H31NO6 |
![Desloratadine IMpurity B](/CAS/20200611/GIF/117796-50-6.gif) |
Desloratadine IMpurity B |
117796-50-6 |
C19H19BrN2 |
![Itraconazole IMpurity B](/) |
Itraconazole IMpurity B |
|
|
![Benzene, 1-(3-chloropropyl)-3-(trifluoroMethyl)-](/CAS/GIF/82258-76-2.gif) |
Benzene, 1-(3-chloropropyl)-3-(trifluoroMethyl)- |
82258-76-2 |
C10H10ClF3 |
![N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/GIF/1260614-73-0.gif) |
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1260614-73-0 |
C13H19N5 |
![2-(5-oxo-5H-chroMeno[2,3-b]pyridin-7-yl)propanoic acid](/CAS/GIF/52549-19-6.gif) |
2-(5-oxo-5H-chroMeno[2,3-b]pyridin-7-yl)propanoic acid |
52549-19-6 |
C15H11NO4 |
![1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)-](/CAS/GIF/1187926-84-6.gif) |
1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)- |
1187926-84-6 |
C18H15F6N3O2S |
![4,5-dihydro-a-(hydroxyMethyl)-a,3-diMethyl-5-oxo-1-phenyl-1H-Pyrazole-4-Methanesulfonic acid](/CAS/GIF/1242471-40-4.gif) |
4,5-dihydro-a-(hydroxyMethyl)-a,3-diMethyl-5-oxo-1-phenyl-1H-Pyrazole-4-Methanesulfonic acid |
1242471-40-4 |
C13H16N2O5S |
![16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers)](/CAS/GIF/1040085-99-1.gif) |
16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione (Mixture of DiastereoMers) |
1040085-99-1 |
C25H34O6 |
![2-BroMo-1-cyclopropyl-2-(3-fluorophenyl)ethanone](/CAS/GIF/1359829-72-3.gif) |
2-BroMo-1-cyclopropyl-2-(3-fluorophenyl)ethanone |
1359829-72-3 |
C11H10BrFO |
![N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide](/CAS/20150408/GIF/198471-06-6.gif) |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide |
198471-06-6 |
C18H16N2O4S |
![N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide](/CAS/20150408/GIF/289472-81-7.gif) |
N-((S)-1-(((S)-1-Hydroxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
289472-81-7 |
C19H24N4O3 |
![(Z)-N-(2-nitrovinyl)acetaMide](/CAS/GIF/1238305-24-2.gif) |
(Z)-N-(2-nitrovinyl)acetaMide |
1238305-24-2 |
C4H6N2O3 |
![cefoxitin iMpurity B](/) |
cefoxitin iMpurity B |
|
|
![pidotiMod iMpurity A](/) |
pidotiMod iMpurity A |
|
|
![Rivaroxaban iMpurity A](/CAS/20180906/GIF/931204-39-6.gif) |
Rivaroxaban iMpurity A |
931204-39-6 |
C19H20ClN3O6S |
![R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester](/CAS/20150408/GIF/1268719-66-9.gif) |
R-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-Methyl-10-(4-Methyl-1-piperazinyl)-7-oxo- Methyl ester |
1268719-66-9 |
C19H22FN3O4 |
![Ticagrelor Sulfone](/CAS/20150408/GIF/274693-39-9.gif) |
Ticagrelor Sulfone |
274693-39-9 |
C23H28F2N6O6S |
![2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol](/CAS/20150408/GIF/CB02668497.gif) |
2-(((3aR,4S,6R,6aS)-6-(7-aMino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-2,2-diMethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
1858267-99-8 |
C17H26N6O4S |
![LevosiMendan iMpurity](/) |
LevosiMendan iMpurity |
139052-02-1 |
|
![rac Cinacalcet HCl](/CAS/20211123/GIF/1025064-33-8.gif) |
rac Cinacalcet HCl |
1025064-33-8 |
C22H22F3N |
![AztreonaM IMpurity E](/) |
AztreonaM IMpurity E |
|
|
![Dasatinib IMpurity 1](/) |
Dasatinib IMpurity 1 |
|
|
![Deferasirox IMpurity 1](/) |
Deferasirox IMpurity 1 |
|
|
![Doxycycline Hyclate IMpurity F](/CAS/20180808/GIF/122861-53-4.gif) |
Doxycycline Hyclate IMpurity F |
122861-53-4 |
C23H25NO8 |
![IpratropiuM BroMide IMpurity E](/CAS/20150408/GIF/CB02674528.gif) |
IpratropiuM BroMide IMpurity E |
183626-76-8 |
C19H27NO3 |
![Minoxidil IMpurity D](/CAS/GIF/75105-16-7.gif) |
Minoxidil IMpurity D |
75105-16-7 |
C11H12N4O4S |
![Ribavirin IMp. D (EP)](/) |
Ribavirin IMp. D (EP) |
|
|
![SalMeterol IMpurity C](/CAS/20150408/GIF/CB02675646.gif) |
SalMeterol IMpurity C |
|
C25H37NO4 |
![SulbactaM IMpurity F](/) |
SulbactaM IMpurity F |
|
|
![N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/CB02681126.gif) |
N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
|
C32H26N4O2 |
![Epalrestat iMpurity](/CAS/20210111/GIF/109801-00-5.gif) |
Epalrestat iMpurity |
109801-00-5 |
C13H18O |
![5-Oxo Pitavastatin](/CAS/GIF/222306-15-2.gif) |
5-Oxo Pitavastatin |
222306-15-2 |
C25H22FNO4 |
![(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one](/CAS/20150408/GIF/1312077-05-6.gif) |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
![2-Hydroxy Cephalexin](/CAS/GIF/215172-75-1.gif) |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
![3-(9H-Carbazol-4-yloxy)-1,2-propanediol](/CAS/20150408/GIF/123119-89-1.gif) |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
![4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide](/CAS/20150408/GIF/1330632-46-6.gif) |
4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide |
1330632-46-6 |
C12H16N2OS2 |
![9-MethoxyMethyl Guanine](/CAS/GIF/1202645-50-8.gif) |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
![ClindaMycin 3-PalMitate](/CAS/20211123/GIF/68225-59-2.gif) |
ClindaMycin 3-PalMitate |
68225-59-2 |
C34H63ClN2O6S |
![α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol](/CAS/GIF/333749-57-8.gif) |
α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol |
333749-57-8 |
C24H34N2O6 |
![Ticagrelor IMpurity E](/CAS/20210111/GIF/1402150-34-8.gif) |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
![Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)-](/CAS/20150408/GIF/881995-73-9.gif) |
Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)- |
881995-73-9 |
C16H20F3NO4 |
![Bosutinib Impurity 1](/CAS/20200611/GIF/1460227-29-5.gif) |
Bosutinib Impurity 1 |
1460227-29-5 |
C18H13Cl2N3O3 |
![Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate)](/CAS/20150408/GIF/1447715-44-7.gif) |
Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) |
1447715-44-7 |
C18H31NO4 |
![Dabigatran iMpurity F](/CAS/20211123/GIF/1642853-67-5.gif) |
Dabigatran iMpurity F |
1642853-67-5 |
C19H20N4O4 |
![Decitabine iMpurity 4](/CAS/20180713/GIF/863396-35-4.gif) |
Decitabine iMpurity 4 |
863396-35-4 |
C6H12O4 |
![Gliclazide iMpurity D](/CAS/20200515/GIF/1136426-19-1.gif) |
Gliclazide iMpurity D |
1136426-19-1 |
C15H20N2O3S |
![Losartan IMpurity C (Isolosartan)](/CAS/20150408/GIF/114799-13-2.gif) |
Losartan IMpurity C (Isolosartan) |
114799-13-2 |
C22H23ClN6O |
![Posaconazole DiastereoisoMer interMediate 2](/CAS/20180808/GIF/166583-12-6.gif) |
Posaconazole DiastereoisoMer interMediate 2 |
166583-12-6 |
C21H21F2N3O4S |
![Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate))](/CAS/20150408/GIF/1011758-03-4.gif) |
Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate)) |
1011758-03-4 |
C19H21N3S |
![TaMsulosin IMpurity B](/CAS/20150408/GIF/CB02707239.gif) |
TaMsulosin IMpurity B |
|
C20H28N2O5S |
![Ticagrelor iMpurity N](/) |
Ticagrelor iMpurity N |
|
|
![Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane)](/CAS/20200515/GIF/25382-33-6.gif) |
Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane) |
25382-33-6 |
C15H18N2 |
![3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-](/CAS/20150408/GIF/492444-39-0.gif) |
3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]- |
492444-39-0 |
C19H23ClN4O2 |
![Vardenafil Oxopiperazine (IMpurity)](/CAS/20200611/GIF/448184-58-5.gif) |
Vardenafil Oxopiperazine (IMpurity) |
448184-58-5 |
C21H26N6O5S |
![IverMectin B1 Aglycon](/CAS/20180808/GIF/73162-95-5.gif) |
IverMectin B1 Aglycon |
73162-95-5 |
C34H50O8 |
![9α-BroMobudesonide](/CAS/20180808/GIF/313474-59-8.gif) |
9α-BroMobudesonide |
313474-59-8 |
C25H33BrO6 |
![N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxaMide (Zopiclone IMpurity)](/CAS/20150408/GIF/349125-10-6.gif) |
N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxaMide (Zopiclone IMpurity) |
349125-10-6 |
C10H7ClN4O |
![2-Methyl SiMvastatin (Mixture Of DiasteroisoMers)](/CAS/20210111/GIF/774611-54-0.gif) |
2-Methyl SiMvastatin (Mixture Of DiasteroisoMers) |
774611-54-0 |
C26H40O5 |
![Desacetyl-7-ACA Lactone](/CAS/20200611/GIF/184696-69-3.gif) |
Desacetyl-7-ACA Lactone |
184696-69-3 |
C8H8N2O3S |
![5,6-DiMethoxy-2-[(4-piperidyl)Methyl]indane Hydrochloride (Donepezil IMpurity)](/CAS/20150408/GIF/1034439-43-4.gif) |
5,6-DiMethoxy-2-[(4-piperidyl)Methyl]indane Hydrochloride (Donepezil IMpurity) |
1034439-43-4 |
C17H26ClNO2 |
![CarfilzoMib IMpurity](/CAS/20211123/GIF/1541171-65-6.gif) |
CarfilzoMib IMpurity |
1541171-65-6 |
C41H61N5O10S |
![BendaMustine IMpurity](/) |
BendaMustine IMpurity |
|
|
![D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester](/CAS/20180808/GIF/1496552-28-3.gif) |
D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester |
1496552-28-3 |
C22H29FN3O9P |
![D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)-](/CAS/20180906/GIF/842133-16-8.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)- |
842133-16-8 |
C24H26O5S |
![(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile](/CAS/20150408/GIF/1150310-15-8.gif) |
(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile |
1150310-15-8 |
C15H15N3O5 |
![(2E)-2-Cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide](/CAS/20150408/GIF/857629-79-9.gif) |
(2E)-2-Cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide |
857629-79-9 |
C16H19N3O5 |
![(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/CAS/20150408/GIF/149709-59-1.gif) |
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate |
149709-59-1 |
C25H31NO4 |
![1-(3-AMinopropyl)-4-(2-Methoxyphenyl)piperazine 97%](/CAS/20150408/GIF/20529-23-1.gif) |
1-(3-AMinopropyl)-4-(2-Methoxyphenyl)piperazine 97% |
20529-23-1 |
C14H23N3O |
![(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/404874-94-8.gif) |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
![(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/CB02735623.gif) |
(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one |
|
C20H21NO4 |
![Posaconazole iMpurity 4](/CAS/20200611/GIF/2125944-53-6.gif) |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
![Everolimus Ring-Opening Impurity](/CAS/20180808/GIF/1708118-13-1.gif) |
Everolimus Ring-Opening Impurity |
1708118-13-1 |
C53H83NO14 |
![Topiroxostat Impurity 6](/CAS/20200611/GIF/2044704-63-2.gif) |
Topiroxostat Impurity 6 |
2044704-63-2 |
C7H8N4O2 |